< Back to previous page
18th International Myeloma Workshop 2021
Journal Contribution - Journal Article
The diagnostic and therapeutic landscape of multiple myeloma has been in constant evolution, resulting in many novel treatment opportunities for patients with MM, though many challenges remain in providing optimal care for patients with MM. In this article, several recent updates with regard to the diagnosis and treatment of MM, as presented at the 18th International Myeloma Workshop (IMW), have been summarised. In this summary, two main topics have been highlighted: 1) early treatment of high-risk smouldering MM, in combination with the development of non-invasive methods for risk stratification of smouldering MM, using circulating tumour cells and 2) updates on trials regrading novel treatment modalities, including novel combination regimens in newly diagnosed and relapsed MM patients, as well as novel immune therapies, with a focus on CAR-T cell therapy and bispecific antibodies
Journal: Belg. J. Hematol.
Keywords:Multiple myeloma, CAR-T, bispecific antibodies, Smouldering myeloma